Abstract
Primary Malignant Melanoma of the Esophagus (PMME) is an extremely rare cancer of the esophagus, accounting for 0.1–0.8% of all oro-esophageal cancers and <0.05% of all melanoma subtypes, with an estimated incidence of 0.0036 cases per million/year. We conduct a careful analysis of the literature starting from 1906 to the beginning of 2022, searching the PubMed, Science.gov, Scopus and Web of Science (WoS) databases. A total of 457 records were initially identified in the literature search, of which 17 were duplicates. After screening for eligibility and inclusion criteria, 303 publications were ultimately included, related to 347 patients with PMME. PMME represents a very rare entity whose very existence has been the subject of debate for a long time. Over time, an increasing number of cases have been reported in the literature, leading to an increase in knowledge and laying the foundations for a discussion on the treatment of this pathology, which still remains largely represented by surgery. In recent times, the possibility of discovering greater mutations in gene hotspots has made it possible to develop new therapeutic strategies of which nivolumab is an example. Future studies with large case series, with clinicopathological and molecular data, will be necessary to improve the outcome of patients with PMME.
Reference306 articles.
1. Ein Fall von primarem Melanom des Osopagus;Bauer;Arb. Geb. Pathol. Anat. Inst. Tub.,1906
2. Multifocal Amelanotic Melanoma of the Hard Palate: A Challenging Case
3. Clinical patterns and management of primary mucosal melanoma: a single centre experience
4. Melanoma in The Gastrointestinal Tract
5. Portmann Mélano-carcinome primitif de l’oesophage [Primary melanocarcinoma of the esophagus];Puyo;Rev. Laryngol. Oto.l Rhinol.,1950
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献